Aminocaproic acid

Also known as: ε-aminocaproic acid ε-Ahx 6-aminohexanoic acid

Active ingredient description

Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
B02AA01
Aminocaproic acid
B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AA Amino acids
Discover more medicines within B02AA01

Medicines

Aminocaproic acid is the active ingredient of these drugs:

Drug
Countries
AMICAR

United States

CAPROCAT

Ecuador

IPSILON

Brazil

Aminocaproic acid is also found within below combination drugs:

DAIGAKU

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
AMICAR Solution, Tablet
Structured Product Labeling (SPL)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 131.173 g/mol

External identifiers

CAS Substance: 60-32-2
DrugBank Drug: DB00513
KEGG Drug: D00160
RxNorm Ingredient: 99
SNOMED-CT Concept: 59882007
Aminocaproic acid (substance)
UNII Identifier: U6F3787206
AMINOCAPROIC ACID
 
Next: Usage >